The information and analytical newspaper Pharmvestnik has announced the results of its annual Rating of the Most Influential Pharmaceutical Market Entities at year-end 2020.
This year, for the first time, the research was conducted by Bionika Digital. The influence rating winners were determined by 249 experts representing 49 regions of Russia. According to Pharmvestnik, the sample of respondents included healthcare professionals, employees of pharmacy chains, distributors and manufacturers, representatives of healthcare administrative agencies and scientific community. The vote collection and processing system underwent an independent audit by the audit and consulting company KPMG.
Following the results of 2020, Pharmstandard takes over the leadership of TOP-10 Russian pharmaceutical manufacturers with the greatest impact on the pharmaceutical market in 2020:
|
National Manufacturing Companies |
||
|
Rating |
Manufacturer |
Relative index |
|
1 |
Pharmstandard |
100 |
|
2 |
R-Pharm Group manufacturing companies |
66 |
|
3 |
Biocad |
50 |
|
4 |
Solopharm |
46 |
|
5 |
Vertex |
44 |
|
6 |
Akrikhin |
43 |
|
7 |
Binnopharm Group (plants: Binnopharm, Sintez, Biocom, Alium) |
42 |
|
8 |
OTCPharm |
40 |
|
9 |
Nizhpharm |
38 |
|
10 |
Ozon |
37 |
|
Source: Bionika Digital |
||
| Back | Print out |
